Hydromer, a world-wide supplier of specialty coatings for medical devices and industrial applications, is excited to announce that Cam Cruickshank, Ph.D. has joined the Hydromer Board of Directors via unanimous vote.
Cam Cruickshank, Ph.D. currently serves as the President of Cabarrus College of Health Sciences, a part of Advocate Health, which is the fifth-largest hospital network in the United States. Advocate Health has more than 150,000 employees, operates 67 hospitals, and offers more than 1,400 care locations in Alabama, Illinois, Georgia, North Carolina, South Carolina, and Wisconsin. Dr. Cruickshank works at Cabarrus College’s hospital campus located in Concord, North Carolina and has held this position since March 2020. Prior to this position, Dr. Cruickshank’s executive experience spans more than 15-years and includes serving various other executive roles for other institutions, as a consultant, and as an entrepreneur.
Dr. Cruickshank is a person with strong financial acumen and takes much pride in managing operating budgets which finish the fiscal year favorable to budget. As the Chief Enrollment Officer at The University of Toledo, Cam was responsible for developing marketing, recruitment, financial aid, and retention strategies. While serving as the Chief Operating Officer at Madonna University, Dr. Cruickshank managed the University’s operating budget.
Dr. Cruickshank brings extensive board room experience. In addition to more than 15-years of providing board presentations, his current board appointments include the Salvation Army of Greater Charlotte, the Cabarrus Healthcare Foundation, and the Cabarrus Entrepreneurship Council. Dr. Cruickshank utilizes his financial management experiences as a member of the Finance Committee of the Salvation Army of Greater Charlotte and the Investment Committee of the Cabarrus Healthcare Foundation. He also serves as an advisor and mentor for start-up companies in the areas of educational technology and higher education services.
A native of Windsor, Ontario, Canada, Cam holds a Bachelor of Science degree from the University of Windsor, a Master of Education from Bowling Green State University, a Master of Business Administration from Tiffin University, and a doctoral degree in higher education administration from The University of Toledo. He lives in Huntersville, North Carolina with his wife Margarita and two of their four children. Cam Cruickshank, Ph.D. serves as the fifth member of the Hydromer Board of Directors and is replacing Mr. Dieter Heineman (88) who steadfastly and loyally served on the Hydromer Board since 1991. His resignation was not as a result with any disagreements with the Company or any matter related to the Company’s operations, policies, or practices.
“With Hydromers proud 40-year track record of innovation and remarkable customer service in the growing and mission critical world of medical device surface modification we are excited to add Cam Cruickshank’s healthcare and financial expertise as a member of the Hydromer Board of Directors. We also wish to gratefully thank Mr. Dieter Heinemann for his strong resolve, many powerful insights and great direction as an independent Board member over the last three decades” said Peter M. von Dyck, Hydromer CEO. About Hydromer® Hydromer®, Inc & Subsidiary (the “Company”) is an ISO 9001:2015 global business-to-business (B2B) surface modification and coating solutions provider offering polymer research & development, and manufacturing services capabilities for a wide variety of applications. We are a U.S. public corporation domiciled in Concord, NC. Our customers are located across the United States of America, Europe, and Asia-Pacific. The Company was established in 1980, originally incorporated in the State of New Jersey. We are a U.S. Food and Drug Administration (FDA), Good Manufacturing Practice (GMP), International Organization for Standardization (ISO) 13485, and International Organization for Standardization (ISO) 9001 production facility. For over four decades, the Company has developed value-added solutions to serve businesses in domestic and international markets, in a wide range of industries. We manage numerous global B2B services such as, coating services, research and development, analytical testing, technology transfer, and dedicated machinery building, installation, and support. We have successfully developed numerous proprietary formulations and secured many patents worldwide at separate times throughout our history including, anti-microbial, anti-fog, anti-frost, condensation-controlling, hydrophilic and thromboresistant coatings.
Mr. Michael Torti has vast experience in B2B sales and marketing of complex manufactured goods and medical devices and as of January 9th, 2023, has joined the Hydromer team in the capacity of Vice President of Global Sales, Marketing and Business Development – reporting directly to Mr. Peter M. von Dyck, Chief Executive Officer.
Mr. Torti is a Performance-Driven Business leader with strong sales, market development, revenue growth and company leadership skills – with over thirty years of experience. Mike began his career as a Field Sales Engineer, covering a multi-state territory for a global manufacturing company. Through strong performance, he rose through the ranks with positions of increasing scope and management responsibility. Possessing decades of experience in the manufacturing sector, serving companies of all sizes.
His corporate background includes positions as the Managing Director (Repi LLC), Vice President – Sales and Marketing (Lexington Precision Corporation), Director of Sales, North America (Nypro Healthcare), President (Rondo-Pak), Group Vice President – CMO (Applied Tech Products, Inc.), and Director of Sales (Dynacast, Inc.).
Michael’s academic background includes a Bachelor of Science Degree in Management from the State University of New York at Binghamton. He also received additional professional development in schools such as Warwick School (Coventry, England).
“With his extensive sales and market development skills – in addition to his deep technical knowledge and considerable track record of driving revenue growth, we feel that Michael is a wonderful addition to our Leadership Team to drive sales and help Hydromer expand its presence in the growing medical device and industrial surface modification marketplace” said Peter M. von Dyck, Hydromer CEO.
Hydromer, a world-wide supplier of coatings for medical devices and industrial applications, is excited to announce the addition of Cortney Wells as our new Director of Finance.
Please read the press release announcement link below for further details.
https://finance.yahoo.com/news/hydromer-announces-addition-cortney-wells-163800152.html
Hydromer, a world-wide supplier of coatings for medical devices and industrial applications, is excited to announce that Hydromer will be exhibiting at the upcoming MD&M South Show in Charlotte (Jun 14-16) and ready to meet you and help augment your products with our over 40 years of polymer, MFG and specialty surface coatings solutions and needs.
Come meet us at our booth #2112 to discuss how Hydromer can support your device coating needs and also offer our services to bring your technologies faster to market.
Interested? Click on the link below for a Free Expo Pass or discounted rate on attending the various events:
Check out Hydromer booth listing and capabilities here:
Hydromer New Facility-40th Anniversary_Press Release_Publication 09-22-2021
Concord, NC, September 22, 2021 (GLOBE NEWSWIRE) via NewMediaWire — Hydromer, Inc. (the “Company”) (HYDI:OTC)
Hydromer, a world-wide supplier of coatings for medical devices and industrial applications, is excited to announce that our brand-new facility with extensive new capabilities is fully operational, marking the proud occasion of serving global customers now for over 40 years. Located in Concord (suburb of Charlotte), North Carolina, our new facility is a fully FDA certified, ISO9001:2015 and ISO13485:2016 approved site, designed per the latest specifications to accommodate all the Company’s functions under one roof, offering the following notable services:
– Collaborative research and development (R&D) and manufacturing of coating formulations with production capabilities ranging from initial customer product prototype to scale-up to large quantities, including but not limited to, contract development and supply of custom coatings per customer’s needs.
– Coatings that can be heat or UV-cured, in solvent and water base versions to accommodate any type of coating requirements.
– Offering a wide range of surface modification processes such as corona, plasma treatment, solvent-cleaning and others, for difficult materials that are becoming the norm in many medical interventional devices such as microcatheters and endoluminal surgeries.
– Very large, modular ISO-class 8 clean room to accommodate customers’ devices of various sizes and quantities, including capabilities to coat devices up to 20-FT (600 CM) in length.
– Precision coating under magnification for micro-devices with strict tolerances.
– Expertise in coating complex devices like balloons, intricate IDs, multi-lumen and others, including emerging 3-D printed parts used in device development.
– Extensive analytical capabilities such as Gas Chromatography with Mass Spectroscopy (GC-MS), High Performance Liquid Chromatography (HPLC), Fourier Transmission Infra-Red (FTIR), Spectrophotometers, Contact Angle, Ultra-High resolution video scanning microscope, and other specialized scientific instrumentation.
– Extensive testing capabilities, including American Society for Testing and Materials (ASTM), International Organization for Standardization (ISO), The Conformitè Europëenne (CE) and Other standardized methods for friction/pinch force, abrasion resistance, light transmittance, hardness, adhesion, surface tension and others.
– Customized coating equipment design services developed in-house and tailored to meet customers’ specific needs.
– Quality Assurance offering OQ & PQ validations for customer devices, both new and innovative devices, as well as reprocessed devices, to ensure customer requirements are met.
Our coating formulations marketed under HYDROMER™, LUXERE™, BRILLIANZ™, and GLACIAL™ brands offer highest lubricity, outstanding durability, lowest particulate, fog and frost control, thrombo-resistance, and many other sought-after performances that customers require to differentiate their medical devices and industrial products. Most of our medical grade coatings have FDA MAF files to assist our customers with their regulatory submissions.
“We are proud of our 40-year heritage, proven innovation and remarkable customer service to benefit our smaller and large size customers. We are very excited to add these additional capabilities to continue the journey as a “one-stop shop/ full-service provider” of world-class products and services to customers around the world” said Peter M. von Dyck, Hydromer CEO.
Hydromer’s legacy of innovation provides many technologies and areas of expertise that are in high demand, from antimicrobial coating capabilities, line of alcohol and plant-based sanitization products, proprietary technologies, including a line of anti-fog and condensation control products; the company expects continual increase in global demand for those products given the current more infection control minded ecosystem.
Mr. Manfred F. Dyck, age 86, stepped down and submitted his resignation Thursday as a member and former Chairman of the Board of Directors of Hydromer Inc. The Board of Directors unanimously excepted his resignation. Mr. Manfred F. Dyck, served as Chairman of the Board of the Company since June 1983 and a Director of the Company since its inception. Mr. Dyck served as Chief Executive Officer of the Company from its inception until October 1986, and from August 1989 until October 2018, when he assumed the role of President of Research and Development. Mr. Dyck has been Chief Executive Officer and a Director of Biosearch Medical Products Inc. from 1975 to 2000 (when Biosearch became a wholly owned subsidiary). He holds a B.S. in Chemical Engineering. He currently still serves in the capacity of Research and Development Advisor for Hydromer.
Mr. Magrane, age 74 was appointed Chairman of the Board of Directors of the Company. Mr. Magrane was the Co-founder, Chief Executive Officer and Chief Financial Officer of Coady Diemar Partners, LLC, a boutique investment bank founded in 2004 and is currently a Senior Advisor to the firm. Mr. Magrane was previously with Goldman Sachs & Co., Inc for 15 years and Blyth Eastman Paine Webber Incorporated / UBS for 11 years. Mr. Magrane has an MBA from Wharton and a BA in Economics from the College of Wooster.
Concord, NC, June 29, 2021 (GLOBE NEWSWIRE) — via NewMediaWire — Hydromer, Inc. (the “Company”) (HYDI:OTC) is pleased to announce that Mr. Craig Hughes has recently joined the Hydromer family in the capacity of Global Business Development Manager reporting to Ravi Rangarajan, Vice President, Sales & Business Development. Mr. Hughes is a seasoned veteran in the chemical industry with extensive knowledge of Coatings and Adhesives among other products. He has multi-faceted experience gained through Product Development, Sales and Business Development roles at well-known global companies. Craig’s academic background is impressive and includes a Ph.D in Organic Chemistry from the University of Florida and a Post Doctoral Research Fellow at the University of Birmingham UK. His most recent professional background includes the positions of Business Development Manager with EMD Performance Materials Corporation, Sales Development roles with Siltech Corporation and Evonik Corporation, and Business Development and R&D Group Leader positions with Clariant Corporation.
“The addition of this proven industry veteran will further empower Hydromer in taking a more aggressive approach in the vast specialty polymer and surface coatings market. Hydromer is better positioned to expand and grow upon our proven solutions for various applications in the medical and healthcare segments,” said Ravi Rangarajan, VP Sales & Marketing, Hydromer.
Hydromer, Inc. is an innovative ISO 9001:2015 technology-focused company engaged in the business of inventing, developing, patenting, licensing, manufacturing and selling hydrophilic polymer-based Coatings for Medical Device, Health Care, and Industrial market segments. Hydromer also provides highly specialized medical coating services and coating equipment, is FDA registered and ISO 13485 & ISO9001 certified.
For the latest information about Hydromer, Inc. and its products, please visit our web site at www.hydromer.com
Concord, NC – (NewMediaWire) – May 20, 2021 – Hydromer, Inc. (the “Company”) (HYDI:OTC) is proud to announce it has been selected as the key coatings and services partner for Avinger, Inc.’s intravascular image-guided, catheter-based systems for diagnosis and treatment of patients with Peripheral Artery Disease (PAD).
Avinger’s best-in class product lines that deploy Hydromer’s coatings include Pantheris®, the first ever image-guided atherectomy device; Ocelot, the first ever image-guided CTO crossing device; and the new Tigereye™ next generation image-guided CTO crossing device.
“Hydromer® is honored to provide our patented hydrophilic coatings and services for Avinger’s groundbreaking medical devices,” said Ravi Rangarajan, Hydromer’s VP of Sales & Marketing. “Our hydrophilic coatings play a key role enabling Avinger’s cutting-edge devices to go further, faster, and more accurately into the patient’s vasculature, while also reducing injury to the inside of patients’ arterial walls.”
“Hydromer’s hydrophilic coatings provide important advantage in our growing catheter-based image-guided treatments for PAD,” said Jeff Soinski, President and CEO of Avinger. “We appreciate the significant benefits that Hydromer’s proprietary hydrophilic coatings bring to our catheters and the long-standing partnership of the professionals at Hydromer in bringing this important technology to the market.”
About Hydromer®
Hydromer® is a leading global surface modification and coatings solutions provider. As a trusted partner to companies worldwide, our solutions add value to our clients’ products so that they can stand out in the marketplace. We are an innovation-driven, customer-centered organization with a focus on meeting our clients’ needs.
Hydromer, Inc.
800-287-5208
Concord, NC, Dec. 03, 2020 (GLOBE NEWSWIRE) — via NewMediaWire — Hydromer Inc (HYDI:OTC) has signed an agreement to sell their Hydromer® First Responder® and HydroProtect® liquid and gel sanitizer lines and coming soon their EscenciaProtect® plant-based sanitizer line on stockd®, an e-Commerce marketplace powered by Premier, a leading healthcare improvement company with more than three decades of healthcare purchasing expertise. Effective 10/20/2020, the agreement allows Hydromer® to make products available for purchase on the stockd marketplace.
Hydromer® will feature their sanitizer lines which include, Hydromer® FirstResponder®, a hospital strong liquid formulation that is 80% v/v denatured ethyl alcohol that kills up to 99.9% of germs, including COVID-19, HydroProtect® gel sanitizer line that is 75% v/v denatured ethyl alcohol, with aloe vera for soothing hands, and proven to kill 99.9% of germs, and EscenciaProtect® which is a patented, “non-alcohol”, plant-based sanitizer line that provides many benefits over the traditional alcohol-based products, including a barrier of soothing moisturizer that protects your hands from harmful germs and bacteria for up to one hour without re-applying, killing many germs including MRSA, Candida Auris, and COVID-19, on the stockd marketplace. Additionally, the stockd marketplace will feature a Hydromer® brand shop at Hydromer’s Shop.
“Hydromer is very excited to be partnering with Premier Inc’s stockd, a leading online marketplace, to provide our highest quality and highly-in demand sanitizing solutions in the fight against the COVID-19 pandemic to a wide variety of clients,” stated Ravi Rangarajan – VP of Sales And Marketing.
stockd® is an online marketplace that connects sellers to buyers. Built by and for healthcare professionals, the stockd marketplace is powered by Premier, a leading healthcare improvement company that unites an alliance of more than 4,000 U.S. hospitals and health systems and approximately 175,000 other providers and organizations to transform healthcare. Harnessing the experience, relationships, and innovative technology of Premier—along with the knowledge of the healthcare community— the stockd marketplace provides an exceptional digital purchasing experience complete with tools and insights to help businesses thrive. Learn more at www.stockd.com.
ABOUT HYDROMER®
We are actively engaged in the fight against COVID-19 pandemic by manufacturing various products that aid in helping save lives, including our antimicrobial anti-fog coatings for PPE, our antimicrobial hydrophilic coatings for medical devices and our sanitizing product line. We are making our alcohol sanitizer products and our patented non-alcohol sanitizers, available under our Hydromer® First Responder® (FDA Registered), HydroProtect® or EscenciaProtect® brands or privately labeled under your own brand to ensure getting these important products, quickly available to end users during the current status of high demand amidst stricter FDA controls. We have pledged to donate hand sanitizer to local first responders with every order.
Hydromer® is a leading global surface modification and coatings solutions provider. As a trusted partner to companies worldwide, our solutions add value to our clients’ products so that they can stand out in the marketplace. We are an innovation-driven, customer-centered organization with a focus on meeting our clients’ needs.
We are a leader in developing coating formulas and processes that meet a market-driven need for greener, more sustainable solutions. We also offer contract coating services, customized coating equipment, contract manufacturing, and turnkey operations backed by outstanding teams of research and development, customer service, and tech support. We are an FDA, GMP/ISO 13485, and ISO 9001 production facility.
Hydromer
800-287-5208
[email protected]
Concord, NC, Sept. 02, 2020 Hydromer, Inc. (OTC:HYDI) or “the Company” announced today that its plant-based EscenciaProtect™ line of sanitizing products showed significant reduction in growth of COVID-19 virus in recent testing done by the external “Institute for Antiviral Research” lab at the University of Utah. The testing shows statistically significant reduction in the growth of the COVID-19 virus when exposed to Hydromer’s plant-based sanitizer formulations. The study showed that “tested neat and at dilutions at 15-minute and 1-hour contact time intervals, the test samples exhibited virucidal activity, reducing SARS-CoV-2 below the limit of detection resulting in Log Reduction Values of >2.5 (>99%) and >3.5 (>99.9%). Neutral controls did not inhibit virus growth and did not exhibit cytotoxicity.” Previous testing done by other external labs have shown these products to also be effective against a variety of other microbes including NoroVirus, MRSA, Salmonella, E-Coli and others, validating that Hydromer’s EscenciaProtect™ line has broad-spectrum sanitizing capabilities. “Hydromer is very proud to have one of the first greener alternatives to alcohol-based sanitizers, now tested and available in the global response to the COVID-19 pandemic. With so many segments of the market desperate for alcohol-free product, such as schools, retail, airlines and more, we recognized how critical it was to test our proprietary technology against this specific virus. We are very pleased to be in a position now to supply a much-needed alternative to the growing market of sanitizers,” said Peter M. von Dyck, Hydromer CEO. In addition, with performance features such as plant-based, natural, longer lasting moisturization, non-flammable and many others, Hydromer’s patented EscenciaProtect™ line offers a very compelling non-alcohol solution for various sanitation needs. The line is being offered in various formulation formats such as ready-to-use sanitizer, sprayable liquid, ready-to-use hand soap, concentrate additive for formulation, and others. Hydromer looks forward to partnerships and distribution opportunities with other companies to take this unique technology into the hands of end users for various sanitation needs across various market segments.
About Hydromer
We are actively engaged in the fight against COVID-19 pandemic by manufacturing various products that aid in helping save lives, including our anti-fog coatings for PPE, our anti-microbial hydrophilic coatings for medical devices and our sanitizing product line. We are making our alcohol sanitizers per approved guidelines of FDA and also registered with FDA, and non-alcohol sanitizer products, available under our Hydromer First Responder™, HydroProtect™ or EscenciaProtect™ brands or privately labeled under your own brand to ensure getting these important products quickly available to end users during the current status of high demand amidst stricter FDA controls.
Hydromer, Inc.
800-287-5208
[email protected]
Concord, NC, Aug. 18, 2020 (GLOBE NEWSWIRE) — via NEWMEDIAWIRE — Hydromer Incorporated (OTC:HYDI) or “the Company” announced today, as the exclusive coatings supplier and manufacturing partner for N8 Medical’s CeraShield™ coated endotracheal tubes, that the CeraShield™ coating has in recent testing demonstrated the ability to inhibit and reduce the growth of COVID-19 virus on tube surfaces. The testing showed statistically significant reduction in the growth of COVID-19 virus on the tube surface in 60 minutes. Ordinary uncoated endotracheal tubes either allowed increased virus growth or had no inhibitory effect. A clinical study is being planned by N8 Medical’s team.
Ronald Bracken, President and Chief Operating Officer of N8 Medical, said, “Recent COVID-19 research has shown that the virus is able to adhere to plastic surfaces for days and is also able to be aerosolized and inhaled by people in close proximity, including doctors and nurses.” He also added, “COVID-19 patients who become mechanically ventilated will require use of one of plastic endotracheal tubes to connect to the mechanical ventilator, so reducing virus growth on them could provide a meaningful benefit.”
“Hydromer is very proud to be aligned with N8 Medical and views this new data as promising and highly relevant, given the global pandemic,” said Peter M. von Dyck, Chief Executive Officer of Hydromer.
CAUTION: In United States, the CeraShield™ Endotracheal Tube has not been granted marketing approval. These statements have not been evaluated by Health Canada or FDA.
About Hydromer®
Hydromer® is a leading global surface modification and coatings solutions provider. As a trusted partner to companies worldwide, our solutions add value to our clients’ products so that they can stand out in the marketplace. We are an innovation-driven, customer-centered organization with a focus on meeting our clients’ needs.
Nikki Barnes
800-208-0314
[email protected]
Inc.® (HYDI) or “the Company” announced today that it is accelerating production of sanitizers to meet the continued demand received by hospitals, nursing homes, state and local governmental organizations, as well as the increased demand anticipated by the re-opening of the U.S. economy.
Hydromer’s First Responder® “alcohol-based” sanitizer and hand rub products are manufactured in accordance with the US FDA & World Health Organization guidelines and are effective agents against COVID-19 as well as other germs. These products have received a very positive response in the market. Hydromer® has been working actively with regional and national healthcare organizations to supply its much needed First Responder™ line of products to hospitals and other health-related institutions throughout the region and across the USA. In preparation for the imminent re-opening of the U.S. economy, Hydromer® is well positioned to meet the growing demand for sanitizing products. This product line will be essential to all public and private establishments such as, retail, offices, restaurants, banks, casinos, and other businesses to comply with health and safety standards and guidelines imposed by the federal government.
Read the entire press release HERE.
CONCORD, NC, April 24, 2020 (GLOBE NEWSWIRE) — via NEWMEDIAWIRE – Hydromer (OTCQB: HYDI) announced today that it will be the exclusive coating supplier and manufacturing partner for N8 Medical’s CeraShield™ Endotracheal Tube. Health Canada has granted emergency use access marketing approval for the CeraShield™ Endotracheal Tube for all Canadian mechanically-ventilated COVID-19 patients. Read the entire press release HERE.
Health Canada has granted emergency use access marketing approval of the company’s CeraShield™ Endotracheal Tube for all Canadian mechanically-ventilated COVID-19 patients. Read more from N8 Medical’s press release earlier today, HERE.
Concord, NC, March 26, 2020 (GLOBE NEWSWIRE) — via NEWMEDIAWIRE — Hydromer, Inc. (“Hydromer®” or the “Company”) (OTCQB: HYDI) announced today that it is actively engaged in the fight against COVID-19 by immediately scaling up manufacturing of its various hand sanitizers during the current extreme demand and short supply of those critical products. Hydromer is commercializing a variety of sanitizer solutions, including a US FDA & World Health Organization-mandated “alcohol-based” sanitizer version, which is widely needed across the entire spectrum of healthcare, safety, first response and many other critical functions. Hydromer is also rejuvenating its patented “non-alcohol”, plant-based sanitizing and cleaning product line that can provide enhanced benefits over the traditional alcohol-based products. During the current epidemic and COVID-19 outbreak, Hydromer is working with private and public sector entities, including various State and Local government organizations to supply first responders and essential workers with much needed sanitizing products.
“Hand sanitizers are in incredible demand and although the regulations to manufacture them are in some cases temporarily being eased to address the current massive shortage of alcohol, we also see the World Health Organization (WHO) and the FDA seeking to tighten up specifications to ensure quality and authenticity in the labeling and the proper use of ingredients at the right levels,” said Martin von Dyck, Chief Operating Officer (COO). “With this in mind, we see that Hydromer’s 40 year track record, as an FDA certified facility and maker of innovative medical technologies for products that serve the Intensive Care Units and nursing homes will bring precision, credibility, and alternatives to those within this emergency response and with future outbreaks,” said Peter M. von Dyck, Chief Executive Officer (CEO).
Hydromer is actively seeking partnerships, suppliers and sources of alcohol to ensure a steady supply of hand sanitizers, to the healthcare market. Hydromer has also secured a special permit from the ATF (Bureau of Alcohol, Tobacco, Firearms). As an essential business worker and qualified healthcare ICU/emergency response support provider, Hydromer continues its manufacturing operations to supply its regular customers with much needed healthcare, ICU and emergency care products during this time of great need.
Hydromer, Inc. is an innovative ISO 9001:2015 technology-focused company engaged in the business of inventing, developing, patenting, licensing, manufacturing and selling hydrophilic polymer-based products for commercial markets including Medical Device, Pharmaceutical, Biotechnology, Industrial Plastics, Cosmetic and Personal Care. Hydromer also provides highly specialized medical coating services to industry through its FDA registered and ISO 13485:2016 certified Medical Products subsidiary. For the latest information about Hydromer, Inc. and its products, please visit our web site at www.hydromer.com
Or contact us now via phone or email
Hydromer Inc.
1-800-287-5208
[email protected]
CONCORD, NC, March 23, 2020 (GLOBE NEWSWIRE) — via NEWMEDIAWIRE — Hydromer, Inc. (“Hydromer®” or the “Company“) (HYDI) announces that due to the emerging public health impact of the coronavirus outbreak (COVID-19) and to support the health and well-being of its partners and shareholders, its board of directors has decided to postpone indefinitely and until further notice the Company’s Annual Meeting of Shareholders scheduled to be held on March 31, 2020. Shareholders will not be able to attend the Annual Meeting.
CONCORD, NC, March 23, 2020 (GLOBE NEWSWIRE) — via NEWMEDIAWIRE — Hydromer, Inc. (“Hydromer®” or the “Company“) (HYDI) announces that due to the emerging public health impact of the coronavirus outbreak (COVID-19) and to support the health and well-being of its partners and shareholders, its board of directors has decided to postpone indefinitely and until further notice the Company’s Annual Meeting of Shareholders scheduled to be held on March 31, 2020. Shareholders will not be able to attend the Annual Meeting.
Branchburg, NJ, Jan. 14, 2020 (GLOBE NEWSWIRE) — via NEWMEDIAWIRE — Hydromer® will supply its market-leading hydrophilic coating formulations along with custom coating equipment, and provide complete technical support to multiple clients.
Branchburg, NJ, July 12, 2019 (GLOBE NEWSWIRE) — via NEWMEDIAWIRE — Hydromer Inc. (HYDI) or “The Company” announces today, the launch of its next generation website, offering a seamless and interactive user experience with exceptional navigation and viewing on all PCs and smart devices. Hydromer® recognizes the need for speed, quality and rapid technical support that clients seeking advanced polymers and surface coatings require in order to meet their internal product development timelines.
June 4, 2019
Hydromer, Inc. announces the addition of two new members of its Operations and Financial team, as it continues to scale for growth in the rapidly increasing medical and industrial coatings and surface modification markets.
April 24, 2019
Hydromer Inc. (OTC: HYDI) announced today it will be moving its operations to the Charlotte, North Carolina region. Hydromer’s current facilities in Branchburg, New Jersey, built by the company in 1981, were recently sold. The company is eagerly anticipating relocation of its headquarters this summer.
Hydromer, a 39-year old company, is a leader in the field of developing high-performance polymers and surface coatings that are lubricious (slippery), condensation controlling, and hydrophilic (work well in liquid environments). The company’s solutions have been successfully adopted for use in advanced medical devices, aerospace components, personal care products, and for other applications by many of the world’s leading companies. The move to NC is part of Hydromer’s blueprint to continually augment its capabilities so it can provide even more mission-critical technologies and services to its many medical, industrial, and green chemistry customers and markets.
February 19, 2019
Hydromer, Inc. announces today that Mr. Matt J. McGlon has joined the Hydromer team in the capacity of National and Key Accounts Sales Manager. Matt is a seasoned medical device Sales and Account Management professional with over fifteen years of experience. He has a proven track record of achieving aggressive sales growth and introducing new products and technologies in highly competitive markets. Matt has a comprehensive understanding of med-tech products and technologies in specialties such as, Peripheral Vascular and Endoscopic Surgery, Interventional Radiology, Trauma Surgery, Interventional Cardiology, Orthopedics and Sports Medicine.
